MAKROCYCLISCHE INHIBITOREN DES HEPATITIS-C-VIRUS
Inhibitors of HCV of formula (I). and the N-oxides, salts, and stereoisomers thereof, wherein the dashed line represents an optional double bond between atoms C7 and C8; R1 is hydrogen or C1-6alkyl; R2 is hydrogen or C1-6alkyl; and n is 3, 4, 5, or 6; pharmaceutical compositions containing compounds...
Gespeichert in:
Hauptverfasser: | , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | ger |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | ANTONOV, DMITRY LINDSTROEM, MATS STEFAN KAHNBERG, PIA CECILIA ROSENQUIST, ASA ANNICA DE KOCK, HERMAN SAMUELSSON, BENGT BERTIL RABOISSON, PIERRE NILSSON, KARL MAGNUS SIMMEN, KENNETH |
description | Inhibitors of HCV of formula (I). and the N-oxides, salts, and stereoisomers thereof, wherein the dashed line represents an optional double bond between atoms C7 and C8; R1 is hydrogen or C1-6alkyl; R2 is hydrogen or C1-6alkyl; and n is 3, 4, 5, or 6; pharmaceutical compositions containing compounds (I) and processes for preparing compounds (I) are provided. Bioavailable combinations of the inhibitors of HCV of formula (I) with ritonavir are also provided. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ATE496934TT1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ATE496934TT1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ATE496934TT13</originalsourceid><addsrcrecordid>eNrjZDDwdfQO8neOdPbxDHb2cFXw9PPwdPIM8Q9y9VNwcQ1W8HANcAzxDPEM1nXWDfMMCg3mYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxjiGuJpZmlsYmISGGxsSoAQBX5yco</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>MAKROCYCLISCHE INHIBITOREN DES HEPATITIS-C-VIRUS</title><source>esp@cenet</source><creator>ANTONOV, DMITRY ; LINDSTROEM, MATS STEFAN ; KAHNBERG, PIA CECILIA ; ROSENQUIST, ASA ANNICA ; DE KOCK, HERMAN ; SAMUELSSON, BENGT BERTIL ; RABOISSON, PIERRE ; NILSSON, KARL MAGNUS ; SIMMEN, KENNETH</creator><creatorcontrib>ANTONOV, DMITRY ; LINDSTROEM, MATS STEFAN ; KAHNBERG, PIA CECILIA ; ROSENQUIST, ASA ANNICA ; DE KOCK, HERMAN ; SAMUELSSON, BENGT BERTIL ; RABOISSON, PIERRE ; NILSSON, KARL MAGNUS ; SIMMEN, KENNETH</creatorcontrib><description>Inhibitors of HCV of formula (I). and the N-oxides, salts, and stereoisomers thereof, wherein the dashed line represents an optional double bond between atoms C7 and C8; R1 is hydrogen or C1-6alkyl; R2 is hydrogen or C1-6alkyl; and n is 3, 4, 5, or 6; pharmaceutical compositions containing compounds (I) and processes for preparing compounds (I) are provided. Bioavailable combinations of the inhibitors of HCV of formula (I) with ritonavir are also provided.</description><language>ger</language><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110215&DB=EPODOC&CC=AT&NR=E496934T1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110215&DB=EPODOC&CC=AT&NR=E496934T1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ANTONOV, DMITRY</creatorcontrib><creatorcontrib>LINDSTROEM, MATS STEFAN</creatorcontrib><creatorcontrib>KAHNBERG, PIA CECILIA</creatorcontrib><creatorcontrib>ROSENQUIST, ASA ANNICA</creatorcontrib><creatorcontrib>DE KOCK, HERMAN</creatorcontrib><creatorcontrib>SAMUELSSON, BENGT BERTIL</creatorcontrib><creatorcontrib>RABOISSON, PIERRE</creatorcontrib><creatorcontrib>NILSSON, KARL MAGNUS</creatorcontrib><creatorcontrib>SIMMEN, KENNETH</creatorcontrib><title>MAKROCYCLISCHE INHIBITOREN DES HEPATITIS-C-VIRUS</title><description>Inhibitors of HCV of formula (I). and the N-oxides, salts, and stereoisomers thereof, wherein the dashed line represents an optional double bond between atoms C7 and C8; R1 is hydrogen or C1-6alkyl; R2 is hydrogen or C1-6alkyl; and n is 3, 4, 5, or 6; pharmaceutical compositions containing compounds (I) and processes for preparing compounds (I) are provided. Bioavailable combinations of the inhibitors of HCV of formula (I) with ritonavir are also provided.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDDwdfQO8neOdPbxDHb2cFXw9PPwdPIM8Q9y9VNwcQ1W8HANcAzxDPEM1nXWDfMMCg3mYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxjiGuJpZmlsYmISGGxsSoAQBX5yco</recordid><startdate>20110215</startdate><enddate>20110215</enddate><creator>ANTONOV, DMITRY</creator><creator>LINDSTROEM, MATS STEFAN</creator><creator>KAHNBERG, PIA CECILIA</creator><creator>ROSENQUIST, ASA ANNICA</creator><creator>DE KOCK, HERMAN</creator><creator>SAMUELSSON, BENGT BERTIL</creator><creator>RABOISSON, PIERRE</creator><creator>NILSSON, KARL MAGNUS</creator><creator>SIMMEN, KENNETH</creator><scope>EVB</scope></search><sort><creationdate>20110215</creationdate><title>MAKROCYCLISCHE INHIBITOREN DES HEPATITIS-C-VIRUS</title><author>ANTONOV, DMITRY ; LINDSTROEM, MATS STEFAN ; KAHNBERG, PIA CECILIA ; ROSENQUIST, ASA ANNICA ; DE KOCK, HERMAN ; SAMUELSSON, BENGT BERTIL ; RABOISSON, PIERRE ; NILSSON, KARL MAGNUS ; SIMMEN, KENNETH</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ATE496934TT13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>ger</language><creationdate>2011</creationdate><toplevel>online_resources</toplevel><creatorcontrib>ANTONOV, DMITRY</creatorcontrib><creatorcontrib>LINDSTROEM, MATS STEFAN</creatorcontrib><creatorcontrib>KAHNBERG, PIA CECILIA</creatorcontrib><creatorcontrib>ROSENQUIST, ASA ANNICA</creatorcontrib><creatorcontrib>DE KOCK, HERMAN</creatorcontrib><creatorcontrib>SAMUELSSON, BENGT BERTIL</creatorcontrib><creatorcontrib>RABOISSON, PIERRE</creatorcontrib><creatorcontrib>NILSSON, KARL MAGNUS</creatorcontrib><creatorcontrib>SIMMEN, KENNETH</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ANTONOV, DMITRY</au><au>LINDSTROEM, MATS STEFAN</au><au>KAHNBERG, PIA CECILIA</au><au>ROSENQUIST, ASA ANNICA</au><au>DE KOCK, HERMAN</au><au>SAMUELSSON, BENGT BERTIL</au><au>RABOISSON, PIERRE</au><au>NILSSON, KARL MAGNUS</au><au>SIMMEN, KENNETH</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>MAKROCYCLISCHE INHIBITOREN DES HEPATITIS-C-VIRUS</title><date>2011-02-15</date><risdate>2011</risdate><abstract>Inhibitors of HCV of formula (I). and the N-oxides, salts, and stereoisomers thereof, wherein the dashed line represents an optional double bond between atoms C7 and C8; R1 is hydrogen or C1-6alkyl; R2 is hydrogen or C1-6alkyl; and n is 3, 4, 5, or 6; pharmaceutical compositions containing compounds (I) and processes for preparing compounds (I) are provided. Bioavailable combinations of the inhibitors of HCV of formula (I) with ritonavir are also provided.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | ger |
recordid | cdi_epo_espacenet_ATE496934TT1 |
source | esp@cenet |
title | MAKROCYCLISCHE INHIBITOREN DES HEPATITIS-C-VIRUS |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T07%3A00%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ANTONOV,%20DMITRY&rft.date=2011-02-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EATE496934TT1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |